Oncology Imperatives: Decentralized Clinical Trials (DCT)

Listen as Dr. Dave Frakes, vice president and global medical officer for PPD^® Biotech, hosts a discussion with PPD’s decentralized clinical trial experts, Simon Coggins, vice president and digital solutions lead for our hematology and oncology therapeutic unit, Mariah Baltezegar, vice president of peri and post-approval study innovation, and Tim Rich, vice president of consulting innovation and strategy for PPD Digital. They discuss the current state of oncology clinical trials and the benefits of decentralization.